From cancer to infectious diseases to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, there ...

The drug formulation market is projected to expand from USD 1.7 trillion in 2025 to USD 2.8 trillion by 2035, growing at a ...

Navitus, the nation’s first transparent, pass-through pharmacy benefit manager (PBM), released its ninth annual Drug Trend ...

Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease mechanisms and developing life-saving drugs. In recent years, models like ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance generating revenues with ensuring that a new medicine reaches the largest possible ...

Samsung Electronics is likely to spin off its foundry business from the broader semiconductor division, on the same conflict of interest that separated Samsung Biologics from its biosimilar business ...

For example, when the biosimilar drug Retacrit entered the market in ... Amber Jessup’s contributions to study design and writing primarily occurred when she worked at ASPE.

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is ... PBMs, which play a critical role in US pharmaceutical distribution, design and administrate cost-effective ...

Demand for biosimilars is predicted to be expanding at a compound annual growth rate of nearly 18% from $9.4 billion in 2023 to $66.9 billion in 2028 (1). This strong growth reflects both higher ...

Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi ... combining a well-designed and executed clinical study with the design of a high-quality manufacturing process and strong ...